Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
The Lyon Uveitis Study is researching uveitis, which is an inflammation of the eye that can lead to serious problems like vision loss. This study aims to understand the causes of uveitis better and to improve how patients are diagnosed and treated. If you or someone you know has been diagnosed with uveitis and is visiting the Department of Internal Medicine at the Croix-Rousse hospital in Lyon, France, you may be eligible to participate in this study.
Participants will be asked about their medical history, and doctors will perform tests to determine the cause of their uveitis and the treatments being used. By gathering this information, the study hopes to enhance the understanding of uveitis and help doctors provide better care for future patients. It’s important to note that the study is currently recruiting participants, and it is open to all genders aged 65 and older who have been diagnosed with uveitis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of uveitis
- • First consultation in the Department of Internal Medicine at the Croix-Rousse hospital, Lyon, France
- Exclusion Criteria:
- • -
About Hospices Civils De Lyon
Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials